• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
HS20010006 麻疹、腮腺炎、风疹活疫苗 Lyophilized Biological Products Import Drug Application 2001-06-01 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-08-07 view
BS20010007 麻疹、腮腺炎、风疹活疫苗 Lyophilized Biological Products Import Drug Application 2001-04-17 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated view
H20010141 阿莫西林/克拉维酸钾片 Amoxicillin;Potassium Clavulanate Tablet Chemical Drugs Import Drug Application 2001-07-10 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-05-08 view
B20000175 盐酸托泊替康 topotecan hydrochloride Active ingredient Chemical Drugs Import Drug Application 2001-02-26 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated view
AS20000007 白喉-破伤风-无细胞百日咳、灭活脊髓灰质炎和b型流 Other Biological Products Import Drug Application 2000-01-01 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2005-08-11 view
A20000035 消旋卡多曲颗粒剂 racecadotril Granule Chemical Drugs Import Drug Application 2000-01-01 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review view
HS20010020 流行性感冒灭活疫苗 Injection Biological Products Import Drug Application 2002-02-06 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-06-19 view
H20000347 泛昔洛韦 famciclovir Active ingredient Chemical Drugs Import Drug Application 2001-02-26 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2002-05-24 view
AS20000030 Vi多糖伤寒疫疫苗 Other Biological Products New Drug Application 2000-10-31 史克必成(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Approval Completed-Pending Certificated 2001-10-29 view